Mamoru Nishimura

732 total citations
25 papers, 517 citations indexed

About

Mamoru Nishimura is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Mamoru Nishimura has authored 25 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Hepatology and 8 papers in Epidemiology. Recurrent topics in Mamoru Nishimura's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Mamoru Nishimura is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Mamoru Nishimura collaborates with scholars based in Japan, United Kingdom and United States. Mamoru Nishimura's co-authors include Masanori Bun‐ya, Yasuji Oshima, Satoshi Harashima, Kazuya Kariyama, Kazuhiro Nouso, Masayuki Kishida, Toshihiro Higashi, Nozomu Wada, Kohsaku Sakaguchi and Tomonori Senoh and has published in prestigious journals such as Molecular and Cellular Biology, American Journal of Roentgenology and SAE technical papers on CD-ROM/SAE technical paper series.

In The Last Decade

Mamoru Nishimura

24 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mamoru Nishimura Japan 10 196 189 124 98 68 25 517
Xiaohua Hao China 11 188 1.0× 147 0.8× 68 0.5× 84 0.9× 17 0.3× 39 464
Masayuki Yamaguchi Japan 16 238 1.2× 175 0.9× 26 0.2× 71 0.7× 64 0.9× 40 719
Bingyong Zhang China 14 49 0.3× 276 1.5× 63 0.5× 88 0.9× 35 0.5× 25 487
Li-Sha Cheng China 10 52 0.3× 83 0.4× 66 0.5× 142 1.4× 36 0.5× 15 357
Xuezhong Xu China 15 203 1.0× 236 1.2× 38 0.3× 30 0.3× 96 1.4× 43 614
Longlong Wu China 12 103 0.5× 193 1.0× 38 0.3× 35 0.4× 87 1.3× 26 502
Steffi Bösch France 12 31 0.2× 409 2.2× 62 0.5× 59 0.6× 162 2.4× 17 741
Xinggu Lin China 14 70 0.4× 160 0.8× 12 0.1× 52 0.5× 40 0.6× 21 378
Chunping Li China 9 32 0.2× 157 0.8× 44 0.4× 64 0.7× 25 0.4× 21 313

Countries citing papers authored by Mamoru Nishimura

Since Specialization
Citations

This map shows the geographic impact of Mamoru Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mamoru Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mamoru Nishimura more than expected).

Fields of papers citing papers by Mamoru Nishimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mamoru Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mamoru Nishimura. The network helps show where Mamoru Nishimura may publish in the future.

Co-authorship network of co-authors of Mamoru Nishimura

This figure shows the co-authorship network connecting the top 25 collaborators of Mamoru Nishimura. A scholar is included among the top collaborators of Mamoru Nishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mamoru Nishimura. Mamoru Nishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
So, Ryuhei, Kazuya Kariyama, Takahiro Yamagishi, et al.. (2024). A smartphone app-based intervention combined with face-to-face sessions for alcohol dependence at internal medicine clinics: A randomized controlled trial. General Hospital Psychiatry. 90. 68–75. 3 indexed citations
2.
3.
Kariyama, Kazuya, et al.. (2023). Predictive Factors for Recovery from Alcoholic Liver Failure.. PubMed. 77(2). 169–177. 1 indexed citations
4.
Hamada, Kenta, Hiromitsu Kanzaki, Masafumi Inoue, et al.. (2020). Continued Aspirin Treatment May Be a Risk Factor of Delayed Bleeding after Gastric Endoscopic Submucosal Dissection under Heparin Replacement: A Retrospective Multicenter Study. Internal Medicine. 59(21). 2643–2651. 5 indexed citations
5.
Iwamuro, Masaya, et al.. (2018). Intravascular lymphoma with a gastric submucosal tumor.. PubMed. 114(8). 1446–1453. 1 indexed citations
6.
Kariyama, Kazuya, et al.. (2015). Percutaneous Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma. Oncology. 89(Suppl. 2). 19–26. 20 indexed citations
7.
Wada, Nozomu, Kazuhiro Nouso, Kazuya Kariyama, et al.. (2015). Liver Sarcoidosis with Unique MRI Images Using Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid.. PubMed. 69(5). 307–11. 2 indexed citations
8.
Nishimura, Mamoru, Kazuhiro Nouso, Kazuya Kariyama, et al.. (2012). Safety and efficacy of radiofrequency ablation with artificial ascites for hepatocellular carcinoma.. PubMed. 66(3). 279–84. 14 indexed citations
9.
Nishimura, Mamoru, Akinobu Takaki, Naofumi Tamaki, et al.. (2012). Serum oxidative–anti‐oxidative stress balance is dysregulated in patients with hepatitis C virus‐related hepatocellular carcinoma. Hepatology Research. 43(10). 1078–1092. 13 indexed citations
10.
Nouso, Kazuhiro, Kazuya Kariyama, Mamoru Nishimura, et al.. (2011). Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma with Decompensated Cirrhosis. Oncology. 81(1). 39–44. 16 indexed citations
11.
Kariyama, Kazuya, Kazuhiro Nouso, Masayuki Kishida, et al.. (2011). Percutaneous Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma in the Caudate Lobe. American Journal of Roentgenology. 197(4). W571–W575. 37 indexed citations
12.
Fujiwara, Akiko, Kohsaku Sakaguchi, Shinichi Fujioka, et al.. (2008). Fibrosis progression rates between chronic hepatitis B and C patients with elevated alanine aminotransferase levels. Journal of Gastroenterology. 43(6). 484–491. 15 indexed citations
13.
Nishimura, Mamoru, et al.. (2006). Clinical study of Radiofrequency Ablation under Biliary Duct Cooling via Endoscopic Naso-biliary Drainage. Kanzo. 47(3). 123–128. 3 indexed citations
14.
Sakaguchi, Kohsaku, et al.. (2005). Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis.. PubMed. 51(60). 1780–3. 16 indexed citations
15.
Tomita, Junko, Hiroyuki Okada, Motowo Mizuno, et al.. (2005). [A case of ulcerative colitis successfully treated with low-dose warfarin for portal vein thrombosis after colectomy].. PubMed. 102(1). 25–30. 1 indexed citations
16.
17.
Sakaguchi, Kohsaku, Mamoru Nishimura, Yasuhiro Miyake, et al.. (2001). Therapeutic effects of azathioprine in combination with low-dose prednisolone in patients with intractable autoimmune hepatitis type 1.. Okayama University Scientific Achievement Repository (Okayama University). 55(6). 341–7. 6 indexed citations
18.
Tanaka, Masakazu, et al.. (2000). The Innovative Reinforcement Technology of Thin Wall Ceramic Substrate Having High Coatability. SAE technical papers on CD-ROM/SAE technical paper series. 1 indexed citations
19.
Cook, Perry, et al.. (1992). Specificity of heme for hemopoietic recovery from AZT toxicity.. PubMed. 6(2). 79–85. 6 indexed citations
20.
Bun‐ya, Masanori, Mamoru Nishimura, Satoshi Harashima, & Yasuji Oshima. (1991). The PH084 Gene of Saccharomyces cerevisiae Encodes an Inorganic Phosphate Transporter. Molecular and Cellular Biology. 11(6). 3229–3238. 306 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaohua Hao Breakdown of academic impact, for papers by Masayuki Yamaguchi Breakdown of academic impact, for papers by Bingyong Zhang Breakdown of academic impact, for papers by Li-Sha Cheng Breakdown of academic impact, for papers by Xuezhong Xu Breakdown of academic impact, for papers by Longlong Wu Breakdown of academic impact, for papers by Steffi Bösch Breakdown of academic impact, for papers by Xinggu Lin Breakdown of academic impact, for papers by Chunping Li
Rankless by CCL
2026